What is an appropriate intervention when administering hydrocortisone cypionate (Cortef)?

Monitoring the patient's blood glucose level is a crucial intervention when administering hydrocortisone cypionate because corticosteroids, such as hydrocortisone, can cause hyperglycemia. These medications increase glucose production by the liver and decrease the sensitivity of tissues to insulin, leading to elevated blood sugar levels. In patients who already have diabetes or are at risk of developing glucose intolerance, this effect can be particularly significant. Regular monitoring allows for timely adjustments in diabetes management if necessary.

Other interventions, though important in their own right, do not specifically address the direct effects of hydrocortisone on glucose metabolism as effectively as monitoring blood glucose levels does. Monitoring for signs of infection is relevant since corticosteroids can suppress the immune response, but it does not relate directly to the immediate pharmacological effects of hydrocortisone. Similarly, adjusting dosages requires careful consideration and is not appropriate without assessing the overall clinical picture first. Ensuring hydration is generally important but does not specifically address the pharmacological implications of hydrocortisone use. Therefore, monitoring blood glucose effectively ensures patient safety and health management during treatment with hydrocortisone cypionate.